Pharmacokinetic profile and in vivo anticancer efficacy of anagrelide administered subcutaneously in rodents.

Saved in:
Bibliographic Details
Title: Pharmacokinetic profile and in vivo anticancer efficacy of anagrelide administered subcutaneously in rodents.
Authors: Toivanen K; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., De Sutter L; Department of Oncology, Laboratory of Experimental Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium., Wozniak A; Department of Oncology, Laboratory of Experimental Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium., Wyns K; Department of Oncology, Laboratory of Experimental Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium., Merikoski N; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Salmikangas S; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Duan J; Duan Pharmaceutical Consulting Inc., Laval, Canada., Maksimow M; Sartar Therapeutics Ltd., Helsinki, Finland., Lahtinen M; Sartar Therapeutics Ltd., Helsinki, Finland., Böhling T; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Schöffski P; Department of Oncology, Laboratory of Experimental Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium., Sihto H; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Source: Drug delivery [Drug Deliv] 2025 Dec; Vol. 32 (1), pp. 2463433. Date of Electronic Publication: 2025 Feb 10.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9417471 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0464 (Electronic) Linking ISSN: 10717544 NLM ISO Abbreviation: Drug Deliv Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1521-0464
DOI:10.1080/10717544.2025.2463433